Dexamethasone versus dexmedetomidine as an adjuvant to bupivacaine in iliopsoas plane block for hip surgeries

Dexamethasone versus dexmedetomidine as a local anesthetic adjuvant to bupivacaine in ultrasound guided iliopsoas plane block for hip surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202402718826002

Enrollment

100

Registered

2024-02-20

Start date

2024-02-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Control group Group C

Dexamethasone group Group DS

Dexmedetomidine group Group DM

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of either sex patients aged between 21 and 80 ASA grade I, II , III scheduled for unilateral elective hip surgery repair.

Exclusion criteria

Exclusion criteria: • Patient refusal. • Hematological diseases, bleeding or coagulation abnormality. • Sepsis and local skin infection at site of the block. • Known hypersensitivity to the study drugs. • Associated sever uncompensated diseases (cardiac, respiratory, hepatic or renal disease. • Neuromuscular diseases (as myopathies, myasthenia gravies…) • Body mass index (BMI) more than 35 kg/m2. • Psychiatric diseases.

Design outcomes

Primary

Measure	Time frame
duration of analgesia	—

Secondary

Measure	Time frame
quadriceps strength and VAS pain scores ; total opioids consumption, first time out of bed, patient satisfaction, and complications	—

Countries

Egypt

Contacts

Public ContactRania Elmohamady Elbadrawy

Rania E Elbadrawy

raniaelmohamady@gmail.com00201003689480

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026